Finance

Beta
Lists
DRMAW:NASDAQ
Dermata Therapeutics Inc
$0.013
+24.75%
(+0.0025) 1D
Jun 24, 3:22:51 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DRMAW...
Mkt. cap
5.23M
Avg. vol.
3.22K
Volume
57.00
52-wk high
$0.03
52-wk low
$0.01
Beta
1.22
No. of employees
9
Mkt. cap
5.23M
Avg. vol.
3.22K
Volume
57.00
52-wk high
$0.03
52-wk low
$0.01
Beta
1.22
No. of employees
9
News stories
From sources across the web
About Dermata Therapeutics Inc
CEO-
Employees9
Founded2014
Headquarters-
SectorBiotechnology
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
617.84K
504.39K
526.62K
383.72K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.15M
1.26M
1.37M
1.54M
Operating expense
1.77M
1.76M
1.90M
1.93M
Total operating expenses
1.77M
1.76M
1.90M
1.93M
Operating income
-1.77M
-1.76M
-1.90M
-1.93M
Other non operating income
-
-
-
-
EBT including unusual items
-1.70M
-1.69M
-1.86M
-1.85M
EBT excluding unusual items
-1.70M
-1.69M
-1.86M
-1.85M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.70M
-1.69M
-1.86M
-1.85M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
71.64K
68.68K
38.50K
78.68K
Interest expense
-
-
-
-
Net interest expenses
71.64K
68.68K
38.50K
78.68K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more